Shuttle Pharmaceuticals Holdings Inc (SHPH) is not a good buy for a beginner investor with a long-term strategy at this time. The stock lacks strong positive catalysts, has weak financial performance, no significant trading signals, and a neutral technical setup. Given the lack of growth trends and the absence of favorable sentiment or influential trading activity, it is better to hold off on investing in this stock.
The MACD is positive but contracting, RSI is neutral at 55.239, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level of 0.917, with resistance at 1.124 and support at 0.711. Overall, the technical indicators suggest a neutral setup with no strong buy signal.
NULL identified. No recent news or significant trading trends from hedge funds, insiders, or Congress. No AI Stock Picker or SwingMax signals.
The stock has a 40% chance to decline by -0.33% in the next day, -3.05% in the next week, and -3.5% in the next month. Financial performance is weak, with negative EPS and net income, and no revenue growth.
In Q4 2025, the company reported no revenue growth (0% YoY), a net income loss of -$2,614,895 (up 63.59% YoY), and a significant drop in EPS to -0.94 (down -93.25% YoY). Gross margin remains at 0%. Overall, the financials show no signs of growth or profitability.
No analyst ratings or price target changes are available for this stock.
